Steve E. Krognes, Director: Denali Therapeutics DNLI Sell · Filed 24/08/22

Trade details

Type: Insider sale
Amount: $41,085.33
Shares · price: 1,727 sh · $23.79 a share
Held after: 32,677 sh
Stock: Denali Therapeutics DNLI
Person: Steve E. KrognesDirector
Trade date: 24/08/20
Filed: 24/08/22
Days to filing: 2 days

Sold 5.0% of holdings

Share of holding sold: 5.0%

Denali Therapeutics trades, last 26 weeks

What else happened in Denali Therapeutics around then

Filed or reported within 30 days of the trade day · 24/07/21~24/09/19

Steve E. Krognes's recent trades

Steve E. KrognesDirector
Planned saleGuardant Health
Planned sale
Guardant Health
GH
$1.2M
6,674 sh
$1.2M
Filed 09/16
Traded 09/16
Steve E. KrognesDirector
SellGuardant Health
Sell
Guardant Health
GH
$1.2M
9,294 sh
$1.2M
Filed 06/05
Traded 06/04
Steve E. KrognesDirector
Planned saleGuardant Health
Planned sale
Guardant Health
GH
$1.2M
9,294 sh
$1.2M
Filed 06/04
Traded 06/04
Steve E. KrognesDirector
SellDenali Therapeutics
Sell
Denali Therapeutics
DNLI
$69.5K
3,339 sh
$69.5K
Filed 25/01/08
Traded 25/01/07
Steve E. KrognesDirector
Planned saleDenali Therapeutics
Planned sale
Denali Therapeutics
DNLI
$69.5K
3,339 sh
$69.5K
Filed 25/01/07
Traded 25/01/07